Clinical trial NOPRODMMY0001
Myeloma Progression Omics Profling (MPOP) : An Atlas of High-Content Single-Cell Immunophenotyping and Single Cell Transcriptomics in Myeloma and its Precursor States
| Cancers | |
|---|---|
| Organ | Myeloma |
| Trial status | Trial open for recruitment |
| Investigator | |
| Trial type |
Interventional with experimental drug
|
| Academic trial | Non |
| Sponsor | Janssen |
| EudraCT Identifier | 2018-004443-23 |
| Inclusion criteria | Prospective MGUS patients: IgG, IgA or light chain MGUS, as defined by the International Myeloma Working Group (IMWG) Updated Criteria for the Diagnosis of Multiple Myeloma? Prospective SMM patients: IgG, IgA or light chain SMM, as defined by the IMWG Up |
| Last update |